For families and patients wanting more information about Allo Phase 2 Clinical Trial: LEARN MORE

For symptomatic peri- and post menopausal women interested in information regarding clinical trial to test the safety and efficacy of PhytoSERM, a potential alternative to hormone therapy. LEARN MORE

Why does menopause predispose a fifth of women to Alzheimer’s?

The May 2020 issue of Scientific American is dedicated to Alzheimer’s — understanding the disease, the research focused on finding better treatments and a potential cure, and why women are at a greater risk for the disease than men. Dr. Roberta Diaz Brinton, the Center’s director and an internationally recognized expert in Alzheimer’s, talks about how her research has demonstrated sex differences in the disease and the therapeutic strategies being utilized to prevent, delay and treat the disease.

Scientific American – May 2020

Leave a Reply

Your email address will not be published.

The Center for Innovation in Brain Science (CIBS) at the University of Arizona is addressing the challenge that, in the 21st century, there is not a single cure for a single neurodegenerative disease and is focused on four age-associated neurodegenerative diseases: Alzheimer’s, Parkinson’s, Multiple Sclerosis and ALS.

© 2021 Center for Innovation Brain Science. University of Arizona Health Sciences.